SEC Comment Letter 0000000000-24-005165 to Elevation Oncology, Inc. (ELEV) (CIK 0001783032)
Elevation Oncology, Inc. (ELEV) (CIK 0001783032)
Date: May 7, 2024 · CIK: 0001783032 · Accession: 0000000000-24-005165
AI Filing Summary & Sentiment
File numbers found in text: 333-279053
Letter
United States securities and exchange commission logo May 7, 2024 Joseph Ferra, Jr. President and Chief Executive Officer Elevation Oncology, Inc. 101 Federal Street, Suite 1900 Boston, MA 02110 Re:Elevation Oncology, Inc. Registration Statement on Form S-3 Filed May 2, 2024 File No. 333-279053 Dear Joseph Ferra: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ryan Mitteness
Show Raw Text
United States securities and exchange commission logo
May 7, 2024
Joseph Ferra, Jr.
President and Chief Executive Officer
Elevation Oncology, Inc.
101 Federal Street, Suite 1900
Boston, MA 02110
Re:Elevation Oncology, Inc.
Registration Statement on Form S-3
Filed May 2, 2024
File No. 333-279053
Dear Joseph Ferra:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Ryan Mitteness